Homegrown brands’ revenue may grow 13% to ₹2.04 lakh crore by FY2036: Report

The cumulative revenue of Indian brands across gadgets, devices, appliances, and connected car segments has hit ₹60,000 crore in FY2026, and may grow by 13% to ₹2.04 lakh crore by FY2036, Techarc said in a report released recently.

Assuming an accelerated scenario, in which Indian brands gain share in smart and connected segments, the growth rate would be 16%. This will see revenue rising from ₹60,000 crore in FY2026 to ₹1.26 lakh crore in FY2031, and ultimately ₹2.65 lakh crore in FY2036, it said.

“Different product categories and segments covered in this report are expected to grow between 12% and 30% over the next decade in India,” the research agency said in its report titled “Building India’s Global Brands”.

“Weighting these by the current mix of the Index gives an expected growth rate of about 13 per cent a year for Indian brands. An accelerated scenario, in which Indian brands gain share in smart and connected segments, is assumed at 16 per cent,” it added.

The report is based on the analysis of 129 homegrown brands, including Digisol, DishTV, Airtel, Amkette, Blue Star, Garuda Aerospace, Godrej Appliances, Goldmedal, CP Plus, Onida, Lloyd, Intex, and Lava International.

The report underscored that the Prime Minister Narendra Modi’s call for ‘Atmanirbhar Bharat’ (self-reliant India) and ‘vocal for local’ initiatives have been supported by the production-linked incentive (PLI) scheme, Scheme for Promotion of Manufacturing of Electronic Components and

Semiconductors (SPECS), Modified Electronics Manufacturing Clusters scheme (EMC 2.0), India Semiconductor Mission (ISM), and Electronics Component Manufacturing Scheme (ECMS).

However, Techarc underscored that despite progress in electronics and mobile phone production and exports, there are five primary gaps constraining the domestic ecosystem.

These gaps include low value addition; global smartphone brands and electronics manufacturing services (EMS) companies gaining in India; low spending on design and research and development (R&D); scarce availability of patient, long-term capital for hardware; and a patchy ecosystem for testing & verification, tooling, etc.